MedTrace Logo

Procedural Sedation in Renal Sympathetic Denervation

NCT07293273 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2025-12-19

No results posted yet for this study

Summary

This retrospective, single-center study investigates the effects of two different sedation regimens-dexmedetomidine versus fentanyl-propofol-on clinical outcomes in patients undergoing catheter-based renal sympathetic denervation for resistant hypertension. The study focuses on peri-procedural safety, recovery, and overall tolerability of sedation approaches in this interventional setting.

Conditions

  • Hypertension, Resistant
  • Sympathectomy
  • Conscious Sedation
  • Procedural Sedation and Analgesia
  • Dexmedetomidine

Sponsors & Collaborators

  • Ebru Girgin Dinc

    lead OTHER

Principal Investigators

  • Ebru GIRGIN DINC, MD, Anesthesiologist · Koşuyolu Heart Training and Research Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-30
Primary Completion
2025-06-30
Completion
2025-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07293273 on ClinicalTrials.gov